The activation of corticotropin-releasing factor (CRF) receptor subtype 1 (CRF1) plays an important role in the anxiogenic and endocrine responses to stress. We previously demonstrated that central CRF1 mediates exogenous CRF- and psychological stress-induced stimulation of colonic transit. Preliminary data also indicate CRF1 involvement in stress-related visceral hypersensitivity and that CRF2 ligands inhibit gastric emptying similarly as stress does. The overall objectives are to establish the mechanisms through which brain activation of CRF2 alters gastric motor function and CRF1, visceral hypersensitivity and their implication in the gut response to stress.
The first aim will characterize the hypothalamic sites of action of newly discovered selective CRF2 ligands to inhibit gastric motility and the role of brain CRF2 in the gastric response to systemic and psychological stress.
The second aim will test the hypothesis that CRF2 receptor expressed in the nodose ganglia and the dorsal vagal complex/area postrema leads to alterations of gastric and sphincter contractile activity through modulation of vagal afferent and efferent activity. The last aim will establish that CRF1 is involved in stress-related hypersensitivity to colorectal distention through activation of locus coeruleus and paraventricular nucleus neurons. New advances related to the discovery in the brain of two peptides, urocortin II and urocortin III with selective affinity to CRF2 receptors along with the recent development of a selective potent CRF2 antagonist, astressin-2B, selective CRF1 agonists, and CRF1 and CRF2 knockout mice will provide new means to achieve the objectives. Electrophysiological (simultaneous dual gastric vagal afferent and efferent recording and locus coeruleus neuronal activity), neuroanatomical (Fos immunohistochemistry, in situ hybridization and RT-PCR, retrograde tracing and double labeling), neuropharmacological (brain microinjection) and functional (simultaneous recording of gastric and sphincter motility by a novel sonomicrometry method, and gastric and colonic transit) will be used to perform the aims. Unraveling the CRF receptor subtypes and brain pathways underlying stress-induced alterations of gut motor function and viscerosensitity will have important implications in the understanding of stress-related gut alterations and possible implications in functional bowel diseases (irritable bowel syndrome and dyspepsia).

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project (R01)
Project #
5R01DK033061-20
Application #
6796201
Study Section
Special Emphasis Panel (ZRG1-GMA-3 (01))
Program Officer
May, Michael K
Project Start
1983-12-01
Project End
2008-07-31
Budget Start
2004-08-01
Budget End
2005-07-31
Support Year
20
Fiscal Year
2004
Total Cost
$277,594
Indirect Cost
Name
University of California Los Angeles
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
092530369
City
Los Angeles
State
CA
Country
United States
Zip Code
90095
Yuan, Pu-Qing; Wu, S Vincent; Pothoulakis, Charalabos et al. (2016) Urocortins and CRF receptor type 2 variants in the male rat colon: gene expression and regulation by endotoxin and anti-inflammatory effect. Am J Physiol Gastrointest Liver Physiol 310:G387-98
Mulak, Agata; Larauche, Muriel; Biraud, Mandy et al. (2015) Selective agonists of somatostatin receptor subtype 1 or 2 injected peripherally induce antihyperalgesic effect in two models of visceral hypersensitivity in mice. Peptides 63:71-80
Taché, Yvette; Adelson, David; Yang, Hong (2014) TRH/TRH-R1 receptor signaling in the brain medulla as a pathway of vagally mediated gut responses during the cephalic phase. Curr Pharm Des 20:2725-30
Goebel-Stengel, Miriam; Stengel, Andreas; Wang, Lixin et al. (2014) Orexigenic response to tail pinch: role of brain NPY(1) and corticotropin releasing factor receptors. Am J Physiol Regul Integr Comp Physiol 306:R164-74
Karasawa, Hiroshi; Yakabi, Seiichi; Wang, Lixin et al. (2014) Orexin-1 receptor mediates the increased food and water intake induced by intracerebroventricular injection of the stable somatostatin pan-agonist, ODT8-SST in rats. Neurosci Lett 576:88-92
Yakabi, Koji; Harada, Yumi; Takayama, Kiyoshige et al. (2014) Peripheral ?2-?1 adrenergic interactions mediate the ghrelin response to brain urocortin 1 in rats. Psychoneuroendocrinology 50:300-10
Stengel, Andreas; Taché, Yvette (2014) Brain peptides and the modulation of postoperative gastric ileus. Curr Opin Pharmacol 19:31-7
Stengel, A; Taché, Y (2013) Role of NUCB2/Nesfatin-1 in the hypothalamic control of energy homeostasis. Horm Metab Res 45:975-9
Goebel-Stengel, Miriam; Wang, Lixin (2013) Central and peripheral expression and distribution of NUCB2/nesfatin-1. Curr Pharm Des 19:6935-40
Stengel, Andreas; Rivier, Jean; Taché, Yvette (2013) Central actions of somatostatin-28 and oligosomatostatin agonists to prevent components of the endocrine, autonomic and visceral responses to stress through interaction with different somatostatin receptor subtypes. Curr Pharm Des 19:98-105

Showing the most recent 10 out of 158 publications